• Infection in transplantation: what have we learned in 2020?

  • Infection in transplantation: what have we learned in 2020?

  • Infection in transplantation: what have we learned in 2020?

#Infection #Europe

Live Session:

Friday, June 25, 2021 - 12:00 PM (Local time in Frankfurt)
Local time (Corresponding local time at your current location)

Join us:


Register

Add to Calendar

Description:


COVID-19 has had a major impact on every facet of transplantation. There have been pauses in transplantation programs worldwide, together with falls in organ donation rates and changes in the spectrum and presentation of infection. This masterclass will highlight the most important lessons the pandemic has had on our understanding of infection and beyond.

Learning Objectives:


  • Understand the impact of the pandemic on transplantation programs
  • Learn about infection rates and the risk of reinfection
  • Understand the current evidence for treatment of COVID-19 in transplant recipients
  • Review vaccination strategies in donors and recipients

Faculty:


COVID-19 infection in kidney transplant recipients


Carmen Lefaucheur

Nephrologist, Saint-Louis Hospital-APHP
Professor of Nephrology, Paris Diderot University
Paris, France

Carmen Lefaucheur received her qualification as Nephrologist in 2004 from Paris Descartes University. She defended her PhD in Biology and Biotechnology in 2012.

She obtained the “International Transplant Society New Key Opinion Leader Award” in 2010 and the “Prix de la Chancellerie des Universités de Paris” award in 2014.

Her research aims to develop a translational research model in organ transplantation based on a multidisciplinary approach which may connect immunological, histological, molecular and clinical knowledge. She has focused on the clinical relevance of HLA antibodies and their different mechanistic pathways leading to allograft antibody-mediated rejection, thereby addressing the heterogeneity of its phenotypic expression and eventually investigating new tailored potential therapies in transplant populations. 

She is principal investigator of national and international clinical trials dedicated to prophylaxis and treatment of rejection in kidney transplantation. She is actually principal investigator in KTD-Innov and EU-train clinical studies whose goal is to develop and validate innovative tools for early prediction of individual risk prediction for allograft rejection and transplant loss.

Carmen Lefaucheur is involved in the French Speaking Society of Transplantation, in the Banff Conference Scientific Committee and in the Transplantation Society steering committee for guidelines on the treatment of antibody-mediated rejection. 

How has COVID-19 impacted donation activity?


Dale Gardiner

UK Associate Medical Director, Deceased Organ Donation
NHS Blood and Transplant
Consultant in Adult Intensive Care Medicine
Nottingham University Hospitals NHS Trust
United Kingdom

Dr. Dale Gardiner is the UK Associate Medical Director – Deceased Organ Donation, at NHS Blood and Transplant and a Consultant in Adult Intensive Care Medicine at Nottingham University Hospitals NHS Trust.

His professional interests are medical ethics, the diagnosis of death, and deceased organ donation. Dr. Gardiner is chair of Nottingham’s Ethics of Clinical Practice Committee and co-chair of the deceased donation working group for ELPAT. He served for four years as a member of the UK Donation Ethics Committee until its closure in 2016.

Originally, he came from Australia but migrated to the UK in 2002.

Moderator:


Paul Harden

Consultant 
Oxford University Hospitals NHS Trust
Oxford, UK

Schedule (90 min):


  • 05 min

    Welcome and introduction by the Chair
  • 25 min

    Presentation: COVID-19 infection in kidney transplant recipients, Carmen Lefaucheur, France

  • 05 min

    Live Q&A with Carmen Lefaucheur, France

  • 25 min

    Presentation: How has COVID-19 impacted donation activity? Dale Gardiner, UK

  • 05 min

    Live Q&A with Dale Gardiner, UK

  • 20 min

    Interactive panel discussion with audience participation led by the Chair
  • 05 min

    Masterclass closing remarks

Join Our Mailing List


Invalid Input
Invalid Input
Invalid email address

Please select at least one of the newsletters

Ask a Question


Invalid Input
Invalid Input
Invalid email address
Please type in your question

Masterclass Prospectus Request


Submit the following information to receive the downloadable prospectus instantaneously.

Invalid Input
Invalid Input
Invalid email address
Invalid Input
Invalid Input